Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents

A Begleiter1, M K Leith, G McClarty

  • 1Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

Cancer Research
|April 1, 1988
PubMed

Insights

This study investigated resistance to hydrolyzed benzoquinone mustard, a quinone antitumor agent. Resistant cells showed decreased DNA breaks and altered enzyme activity, suggesting complex resistance mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Quinone antitumor agents are vital in cancer therapy, but their precise mechanism of action and resistance pathways are not fully understood.
  • Hydrolyzed benzoquinone mustard's activity is linked to free radical-mediated DNA strand breaks.
  • Understanding quinone drug resistance is crucial for developing more effective cancer treatments.

Purpose of the Study:

  • To investigate the mechanisms of cellular resistance to hydrolyzed benzoquinone mustard, a model quinone antitumor agent.
  • To characterize enzyme activity changes in resistant cell lines.
  • To elucidate the role of the quinone group in antitumor activity.

Main Methods:

  • Isolation and characterization of L5178Y murine lymphoblastic cell lines resistant to hydrolyzed benzoquinone mustard.
  • Assessment of drug sensitivity, DNA strand break formation, and drug uptake in parental and resistant cell lines.
  • Quantification of various enzyme activities, including superoxide dismutase, catalase, glutathione peroxidase, glutathione transferase, and DT-diaphorase.

Main Results:

  • Resistant cell lines (L5178Y/HBM2, L5178Y/HBM10) exhibited reduced sensitivity to hydrolyzed benzoquinone mustard (2.5- to 6-fold).
  • A decrease in DNA single and double strand breaks was observed in resistant cells.
  • Elevated intracellular catalase, glutathione, glutathione transferase, and DT-diaphorase activities were noted in resistant cell lines, alongside reduced drug uptake.

Conclusions:

  • Cellular resistance to hydrolyzed benzoquinone mustard involves decreased DNA damage and alterations in antioxidant enzyme systems.
  • Increased DT-diaphorase and catalase activities appear to be key components of the resistance phenotype.
  • These findings contribute to understanding quinone antitumor agent resistance and may inform future drug development.